Radiotherapy Quality Assurance in the PORTEC-3 (TROG 08.04) Trial

[1]  M. Mix,et al.  The impact of radiotherapy protocol adherence on the outcome of patients with locally advanced NSCLC treated with concurrent chemoradiation: results from the radiotherapy quality assurance of the multicentre international randomized PET-Plan trial. , 2021, Radiotherapy and Oncology.

[2]  Samsara Terparia,et al.  Automatic evaluation of contours in radiotherapy planning utilising conformity indices and machine learning , 2020, Physics and imaging in radiation oncology.

[3]  C. Kirisits,et al.  Implementing an online radiotherapy quality assurance programme with supporting continuous medical education - report from the EMBRACE-II evaluation of cervix cancer IMRT contouring. , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  V. Grégoire,et al.  Radiotherapy Quality Assurance for Head and Neck Squamous Cell Carcinoma , 2020, Frontiers in Oncology.

[5]  H. Putter,et al.  Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial , 2019, The Lancet. Oncology.

[6]  D. Dearnaley,et al.  Radiotherapy Quality Assurance for the CHHiP Trial: Conventional Versus Hypofractionated High-Dose Intensity-Modulated Radiotherapy in Prostate Cancer. , 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

[7]  T. Kasamatsu,et al.  Dummy-run for standardizing plan quality of intensity-modulated radiotherapy for postoperative uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402) , 2019, Radiation oncology.

[8]  Annette Haworth,et al.  Contour variation is a primary source of error when delivering post prostatectomy radiotherapy: Results of the Trans‐Tasman Radiation Oncology Group 08.03 Radiotherapy Adjuvant Versus Early Salvage (RAVES) benchmarking exercise , 2019, Journal of medical imaging and radiation oncology.

[9]  Michael G Jameson,et al.  PO-0823: TRAC: Automated atlas based machine learning QA of contouring accuracy for the PROMETHEUS trial , 2018 .

[10]  H. Putter,et al.  Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  J. Staffurth,et al.  Quality assurance of the SCOPE 1 trial in oesophageal radiotherapy , 2017, Radiation oncology.

[12]  P. Metcalfe,et al.  Results of the Australasian (Trans‐Tasman Oncology Group) radiotherapy benchmarking exercise in preparation for participation in the PORTEC‐3 trial , 2016, Journal of medical imaging and radiation oncology.

[13]  A. Kneebone,et al.  Optimizing Radiation Therapy Quality Assurance in Clinical Trials: A TROG 08.03 RAVES Substudy. , 2015, International journal of radiation oncology, biology, physics.

[14]  M. Tomsej,et al.  Quality assurance for the EORTC 22071–26071 study: dummy run prospective analysis , 2014, Radiation oncology.

[15]  M. Shinoda,et al.  Radiotherapy quality assurance review for a multi-center randomized trial of locally advanced esophageal cancer: the Japan Clinical Oncology Group (JCOG) trial 0303 , 2012, International Journal of Clinical Oncology.

[16]  Brian O'Sullivan,et al.  Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  W. Small,et al.  Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. , 2008, International journal of radiation oncology, biology, physics.

[18]  N. Spry,et al.  Detailed review and analysis of complex radiotherapy clinical trial planning data: evaluation and initial experience with the SWAN software system. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  A. Rockall,et al.  An atlas of the pelvic lymph node regions to aid radiotherapy target volume definition. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[20]  P. Lambin,et al.  Quality Assurance in the EORTC Randomized Trial 22922/10925 Investigating the Role of Irradiation of the Internal Mammary and Medial Supraclavicular Lymph Node Chain Works , 2006, Strahlentherapie und Onkologie.

[21]  R. Reznek,et al.  Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy. , 2005, International journal of radiation oncology, biology, physics.